tiprankstipranks
Jazz Pharmaceuticals Faces DEI Challenges Amidst Executive Order and Growing Scrutiny
PremiumCompany AnnouncementsJazz Pharmaceuticals Faces DEI Challenges Amidst Executive Order and Growing Scrutiny
4d ago
Jazz downgraded to Neutral at Cantor on oncology strategy ‘head-scratcher’
Premium
The Fly
Jazz downgraded to Neutral at Cantor on oncology strategy ‘head-scratcher’
4d ago
Jazz Pharmaceuticals downgraded to Neutral from Overweight at Cantor Fitzgerald
Premium
The Fly
Jazz Pharmaceuticals downgraded to Neutral from Overweight at Cantor Fitzgerald
4d ago
Jazz Pharmaceuticals: Strong Financial Performance and Promising Pipeline Justify Buy Rating
PremiumRatingsJazz Pharmaceuticals: Strong Financial Performance and Promising Pipeline Justify Buy Rating
5d ago
Jazz Pharmaceuticals Reports Strong 2024 Financial Results
Premium
Company Announcements
Jazz Pharmaceuticals Reports Strong 2024 Financial Results
5d ago
Jazz Pharmaceuticals reports Q4 adjusted EPS $6.60, consensus $5.81
Premium
The Fly
Jazz Pharmaceuticals reports Q4 adjusted EPS $6.60, consensus $5.81
5d ago
Akari Therapeutics appoints Samir Patel as CEO
PremiumThe FlyAkari Therapeutics appoints Samir Patel as CEO
2M ago
Jazz Pharmaceuticals Announces CEO Bruce Cozadd’s Retirement Plan
Premium
Company Announcements
Jazz Pharmaceuticals Announces CEO Bruce Cozadd’s Retirement Plan
3M ago
Jazz Pharmaceuticals CEO Bruce Cozadd to retire by end of 2025
Premium
The Fly
Jazz Pharmaceuticals CEO Bruce Cozadd to retire by end of 2025
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100